Physical Consequences of Anorexia Nervosa

Anorexia nervosa is a serious eating disorder that requires both psychological and physical assessment. The malnutrition associated with anorexia nervosa can have significant physical consequences. One of the physical consequences is the loss of pubic and axillary hair, but sufferers develop lanugo hair which results in an overall increase in body hair.

Classically, hypogonadotrophic hypogonadism ensues, which results in amenorrhoea rather than menorrhagia. Hypokalaemia is normally found, which is a consequence of poor nutrient intake and can be exacerbated by the abuse of diuretics and laxatives. Hypotension (low blood pressure) usually features, rather than hypertension. Prolonged QT interval is typically associated with anorexia, and ECG should always be performed as part of the physical assessment.

Treatment Options for earwax: Ear Drops, Microsuction, and Manual Removal

earwax, also known as cerumen, can cause discomfort and hearing problems if it builds up in the ear canal. The first-line treatment for earwax is ear drops, which can soften the wax and make it easier to remove. Microsuction is a safer alternative to irrigation, but it is not widely available. Manual removal using a probe is also an option. However, there is little evidence on the effectiveness of these treatments.

Various types of ear drops can be used, including sodium bicarbonate, sodium chloride, olive oil, and almond oil. Cerumol® is a commonly used proprietary agent. However, the British National Formulary warns against using docusate sodium (Waxsol®, Molcer®) or urea hydrogen peroxide (Exterol®, Otex®) as they may irritate the external meatus.

Regardless of the type of ear drop used, the patient should lie with the affected ear uppermost for 5-10 minutes after applying the drops. While using any type of ear drop appears to be better than no treatment, it is uncertain if one type of drop is more effective than another. Therefore, it is important to seek advice from a healthcare professional before attempting to remove earwax at home.

If topical antibiotics do not provide relief for otitis externa, it is recommended to refer the patient to an ear, nose, and throat (ENT) specialist. This is because the infection can cause swelling and narrowing of the ear canal, making it difficult for antibiotic drops to be effective. In such cases, microsuction and insertion of a pope wick may be necessary, which requires the expertise of an ENT specialist.

Ear syringing should not be performed during an active infection as it will not be helpful.

Steroids are often included in antibiotic ear drops, but they will not be effective if the drops cannot reach the ear canal.

Oral antibiotics, such as ciprofloxacin, may be prescribed alongside topical antibiotics if there is concern of a deep tissue infection. However, this is unlikely in a young and otherwise healthy patient, and the primary treatment remains antibiotic drops.

If necrotising otitis externa is suspected, a CT scan may be helpful, but this would be arranged by an ENT specialist and is not necessary in most cases.

Understanding Otitis Externa: Causes, Features, and Management

Otitis externa is a prevalent condition that often prompts primary care visits in the UK. It is characterized by ear pain, itch, and discharge, and can be caused by bacterial or fungal infections, seborrhoeic dermatitis, or contact dermatitis. Swimming is also a common trigger for otitis externa. Upon examination, the ear canal may appear red, swollen, or eczematous.

The recommended initial management for otitis externa is the use of topical antibiotics or a combination of topical antibiotics with a steroid. However, if the tympanic membrane is perforated, aminoglycosides are traditionally not used. If there is canal debris, removal may be necessary, and if the canal is extensively swollen, an ear wick may be inserted. Second-line options include taking a swab inside the ear canal, considering contact dermatitis secondary to neomycin, or using oral antibiotics such as flucloxacillin if the infection is spreading. Empirical use of an antifungal agent may also be considered.

It is important to note that if a patient fails to respond to topical antibiotics, they should be referred to an ENT specialist. Malignant otitis externa is a more severe form of the condition that is more common in elderly diabetics. It involves the extension of infection into the bony ear canal and the soft tissues deep to the bony canal, and may require intravenous antibiotics. While some ENT doctors disagree, concerns about ototoxicity may arise with the use of aminoglycosides in patients with perforated tympanic membranes.

Understanding Delusions: Types and Associated Mental Illnesses

Delusions are false beliefs that persist despite evidence to the contrary and are not accepted by others in the person’s culture or subculture. There are various types of delusions, each associated with different mental illnesses.

Grandiose delusions are beliefs of exaggerated importance and are often seen in mania. Nihilistic delusions involve a persistent denial of the existence of things or everything, including oneself, and are common in schizophrenia. Delusions of guilt are found in depressive illnesses, while delusions of reference are seen in schizophrenia and mania.

Persecutory delusions involve the belief that the person or someone close to them is being mistreated or spied on, and are common in schizophrenia, depression, and organic mental states. Understanding the different types of delusions and their associated mental illnesses can aid in diagnosis and treatment.

Gynaecological Problems in Children: Vulvovaginitis

In children, gynaecological problems are not uncommon, and vulvovaginitis is the most prevalent disorder. This condition is often caused by poor hygiene, tight clothing, lack of labial fat pads protecting the vaginal orifice, and lack of protective acid secretion found in the reproductive years. Bacterial or fungal organisms may be responsible for the infection, and in rare cases, sexual abuse may present as vulvovaginitis. If there is a bloody discharge, it is essential to consider a foreign body.

It is not recommended to perform vaginal examinations or vaginal swabs on children. Instead, referral to a paediatric gynaecologist is appropriate for persistent problems. Most newborn girls have some mucoid white vaginal discharge, which usually disappears by three months of age.

The management of vulvovaginitis includes advising the child about hygiene, using soothing creams, and applying topical antibiotics or antifungals. In resistant cases, oestrogen cream may be necessary. It is crucial to seek medical attention if the symptoms persist or worsen.

Urgent Referral for Upper GI Endoscopy in a Woman with Recent Onset Anemia and Weight Loss

This woman, aged over 55, has recently developed anemia and has also experienced weight loss. According to the latest NICE guidelines, urgent referral for upper GI endoscopy is necessary in such cases. Routine referrals for CT scan and barium meal are not appropriate. Treating with iron without referral is not recommended as it may delay diagnosis.

The loss of blood from the gastrointestinal tract is a common cause of anemia, and the symptoms experienced by this woman suggest an upper GI cause. Therefore, it is important to refer her for an upper GI endoscopy as soon as possible to identify the underlying cause of her symptoms and provide appropriate treatment. Proper diagnosis and treatment can help prevent further complications and improve the woman’s overall health and well-being.

Proper Application of Topical Corticosteroids

Topical corticosteroids are effective in treating skin conditions, but it is important to apply them correctly. The cream or ointment should be spread thinly on the affected area, but enough should be used to cover it completely. To determine the appropriate amount, the length of cream or ointment expelled from a tube can be measured in terms of a fingertip unit (ftu). One ftu is approximately 0.5 g and is enough to cover an area twice the size of an adult hand.

For example, treating both legs for two weeks requires 14 ftus or 7 g per daily dose. This means that a prescription for 100 g is needed. It is important to know the correct quantity of cream to be prescribed and the volumes used for various parts of the body, as these have been tested in past examinations. By following these guidelines, patients can ensure that they are using topical corticosteroids safely and effectively.

Children with hand, foot and mouth disease do not need to be excluded from childcare or school. Supportive management and simple pain relief are sufficient, and antibiotics are not necessary as the condition is caused by a virus. There is no evidence to support the use of antivirals or chlorhexidine mouthwash. Although the illness is contagious and often occurs in outbreaks at nurseries and schools, NICE guidelines suggest that children should only be kept off if they are too ill to attend.

Hand, Foot and Mouth Disease: A Contagious Condition in Children

Hand, foot and mouth disease is a viral infection that commonly affects children. It is caused by intestinal viruses from the Picornaviridae family, particularly coxsackie A16 and enterovirus 71. This condition is highly contagious and often occurs in outbreaks in nurseries.

The clinical features of hand, foot and mouth disease include mild systemic upset such as sore throat and fever, followed by the appearance of oral ulcers and vesicles on the palms and soles of the feet.

Symptomatic treatment is the only management option available, which includes general advice on hydration and analgesia. It is important to note that there is no link between this disease and cattle, and children do not need to be excluded from school. However, the Health Protection Agency recommends that children who are unwell should stay home until they feel better. If there is a large outbreak, it is advisable to contact the agency for assistance.

Upon examination, there is no actual weakness observed in the limb girdles of a patient with polymyalgia rheumatica. Any perceived weakness is likely due to myalgia, which is pain-induced inhibition of muscles.

The most probable diagnosis for a patient with gradual onset and symmetrical symptoms, such as this woman, is polymyalgia rheumatica. Although the patient reports subjective weakness, it is most likely due to pain rather than actual objective weakness, which is typical of this condition. If there were any visible deformities or true weakness, it would suggest a different diagnosis.

Rotator cuff tendinopathy would not typically present with symmetrical features or significant morning stiffness.

Cervical myelopathy would likely reveal objective weakness during examination, along with other potential symptoms such as clumsiness and numbness/paraesthesia.

Fibromyalgia is an unlikely diagnosis for a patient in this age group and would not typically present with morning stiffness.

Understanding Polymyalgia Rheumatica

Polymyalgia rheumatica (PMR) is a condition commonly seen in older individuals that is characterized by muscle stiffness and elevated inflammatory markers. Although it is closely related to temporal arteritis, the underlying cause is not fully understood, and it doesn’t appear to be a vasculitic process. PMR typically affects individuals over the age of 60 and has a rapid onset, with symptoms appearing in less than a month. Patients experience aching and morning stiffness in proximal limb muscles, along with mild polyarthralgia, lethargy, depression, low-grade fever, anorexia, and night sweats. Weakness is not considered a symptom of PMR.

To diagnose PMR, doctors look for elevated inflammatory markers, such as an ESR greater than 40 mm/hr. Creatine kinase and EMG are typically normal. Treatment for PMR involves the use of prednisolone, with a typical dose of 15mg/od. Patients usually respond dramatically to steroids, and failure to do so should prompt consideration of an alternative diagnosis. Understanding the symptoms and treatment options for PMR can help individuals manage their condition and improve their quality of life.

To manage poorly controlled hypertension in a patient who is already taking an ACE inhibitor, calcium channel blocker, and a standard-dose thiazide diuretic with a potassium level of >4.5mmol/l, the appropriate medication to add would be an alpha- or beta-blocker. Bisoprolol is the correct choice in this scenario. Furosemide is not indicated for hypertension alone, and indapamide is contraindicated as the patient is already taking a thiazide-like diuretic. While an ARB like losartan could replace an ACE inhibitor, it should not be used in combination with one. Spironolactone is not the appropriate choice as the patient’s potassium level is already elevated.

Hypertension, or high blood pressure, is a common condition that can lead to serious health problems if left untreated. The National Institute for Health and Care Excellence (NICE) has published updated guidelines for the management of hypertension in 2019. Some of the key changes include lowering the threshold for treating stage 1 hypertension in patients under 80 years old, allowing the use of angiotensin receptor blockers instead of ACE inhibitors, and recommending the use of calcium channel blockers or thiazide-like diuretics in addition to ACE inhibitors or angiotensin receptor blockers.

Lifestyle changes are also important in managing hypertension. Patients should aim for a low salt diet, reduce caffeine intake, stop smoking, drink less alcohol, eat a balanced diet rich in fruits and vegetables, exercise more, and lose weight.

Treatment for hypertension depends on the patient’s blood pressure classification. For stage 1 hypertension with ABPM/HBPM readings of 135/85 mmHg or higher, treatment is recommended for patients under 80 years old with target organ damage, established cardiovascular disease, renal disease, diabetes, or a 10-year cardiovascular risk equivalent to 10% or greater. For stage 2 hypertension with ABPM/HBPM readings of 150/95 mmHg or higher, drug treatment is recommended regardless of age.

The first-line treatment for patients under 55 years old or with a background of type 2 diabetes mellitus is an ACE inhibitor or angiotensin receptor blocker. Calcium channel blockers are recommended for patients over 55 years old or of black African or African-Caribbean origin. If a patient is already taking an ACE inhibitor or angiotensin receptor blocker, a calcium channel blocker or thiazide-like diuretic can be added.

If blood pressure remains uncontrolled with the optimal or maximum tolerated doses of four drugs, NICE recommends seeking expert advice or adding a fourth drug. Blood pressure targets vary depending on age, with a target of 140/90 mmHg for patients under 80 years old and 150/90 mmHg for patients over 80 years old. Direct renin inhibitors, such as Aliskiren, may be used in patients who are intolerant of other antihypertensive drugs, but their role is currently limited.

Subdividing participant data into smaller groups, known as subgroup analyses, is often used to compare and contrast different subsets. These subgroups can be based on various factors, such as gender or location, and may be used to explore inconsistent findings or to address specific research questions related to patient demographics, interventions, or study types.

Analytical Approaches in Qualitative Research

Analytical approaches are an essential part of qualitative research, which aims to understand the meaning and experience dimensions of human lives and social worlds. Content analysis is a common method used in healthcare research, where interviews are transcribed to produce texts that can be used to generate coding categories and test theories. This involves counting word frequencies, sometimes aided by computer software. Another approach is constant comparison, which is based on grounded theory. It allows researchers to identify important themes in a systematic way, providing an audit trail as they proceed. The method involves developing concepts from the data by coding and analyzing at the same time.

Assessing validity is also crucial in qualitative research. Triangulation compares the results from different methods of data collection or data sources. Respondent validation, or member checking, involves comparing the investigator’s account with those of the research subjects to establish the level of correspondence between the two sets. Bracketing is a methodological device of phenomenological inquiry that requires putting aside one’s own beliefs about the phenomenon under investigation or what one already knows about the subject prior to and throughout the phenomenological investigation. Reflexivity means sensitivity to the ways in which the researcher and the research process have shaped the collected data, including the role of prior assumptions and experience, which can influence even the most avowedly inductive inquiries.

Understanding Incubation Periods and Latent Periods in Diseases

Incubation period refers to the time between exposure to a pathogenic organism and the onset of symptoms. This period can range from minutes to even 30 years, depending on the disease. Latent period, on the other hand, is the time from infection to infectiousness. While the two terms may be synonymous, a distinction is sometimes made between them.

Examples of diseases with short incubation periods include norovirus, influenza, and scarlet fever. Diseases with medium incubation periods include roseola, measles, and pertussis. Mumps, erythema infectiosum, and rubella have long incubation periods, while infectious mononucleosis and hepatitis A have extra-long incubation periods. Hepatitis B has an incubation period greater than six weeks.

Clinical latency occurs in diseases like AIDS, where people infected with HIV may not show any symptoms or signs of AIDS despite having a large viral load. It is important to understand incubation and latent periods in diseases to prevent their spread and manage their symptoms effectively.

For individuals with cellulitis or erysipelas, an antibiotic is necessary. These conditions are characterized by acute inflammation and swelling, with erysipelas having more superficial lesions with a distinct raised margin.

When selecting an antibiotic, consider the severity of symptoms, the location of the infection, the risk of complications, and previous antibiotic use. If the individual was admitted to the hospital due to systemic illness, oral flucloxacillin is the preferred treatment for erysipelas. However, co-amoxiclav should be used for cellulitis near the eyes or nose.

Ciprofloxacin should only be used for specific indications due to its association with Clostridium difficile infection. Doxycycline is not the first choice, and if there is a penicillin allergy, clarithromycin or erythromycin should be used instead of flucloxacillin for erysipelas or cellulitis.

Erythromycin is not the first-line choice, but it may be appropriate if there is a history of penicillin allergy.

Antibiotic Guidelines for Common Infections

Respiratory infections such as chronic bronchitis and community-acquired pneumonia are typically treated with amoxicillin, tetracycline, or clarithromycin. In cases where atypical pathogens may be the cause of pneumonia, clarithromycin is recommended. Hospital-acquired pneumonia within five days of admission is treated with co-amoxiclav or cefuroxime, while infections occurring more than five days after admission are treated with piperacillin with tazobactam, a broad-spectrum cephalosporin, or a quinolone.

For urinary tract infections, lower UTIs are treated with trimethoprim or nitrofurantoin, while acute pyelonephritis is treated with a broad-spectrum cephalosporin or quinolone. Acute prostatitis is treated with a quinolone or trimethoprim.

Skin infections such as impetigo, cellulitis, and erysipelas are treated with topical hydrogen peroxide, oral flucloxacillin, or erythromycin if the infection is widespread. Animal or human bites are treated with co-amoxiclav, while mastitis during breastfeeding is treated with flucloxacillin.

Ear, nose, and throat infections such as throat infections, sinusitis, and otitis media are treated with phenoxymethylpenicillin or amoxicillin. Otitis externa is treated with flucloxacillin or erythromycin, while periapical or periodontal abscesses are treated with amoxicillin.

Genital infections such as gonorrhoea, chlamydia, and bacterial vaginosis are treated with intramuscular ceftriaxone, doxycycline or azithromycin, and oral or topical metronidazole or topical clindamycin, respectively. Pelvic inflammatory disease is treated with oral ofloxacin and oral metronidazole or intramuscular ceftriaxone, oral doxycycline, and oral metronidazole.

Gastrointestinal infections such as Clostridioides difficile, Campylobacter enteritis, Salmonella (non-typhoid), and Shigellosis are treated with oral vancomycin, clarithromycin, ciprofloxacin, and ciprofloxacin, respectively.

Sulfasalazine may cause a reaction in patients who are allergic to aspirin.

Sulfasalazine: A DMARD for Inflammatory Arthritis and Bowel Disease

Sulfasalazine is a type of disease modifying anti-rheumatic drug (DMARD) that is commonly used to manage inflammatory arthritis, particularly rheumatoid arthritis, as well as inflammatory bowel disease. This medication is a prodrug for 5-ASA, which works by reducing neutrophil chemotaxis and suppressing the proliferation of lymphocytes and pro-inflammatory cytokines.

However, caution should be taken when using sulfasalazine in patients with G6PD deficiency or those who are allergic to aspirin or sulphonamides due to the risk of cross-sensitivity. Adverse effects of sulfasalazine may include oligospermia, Stevens-Johnson syndrome, pneumonitis/lung fibrosis, myelosuppression, Heinz body anaemia, megaloblastic anaemia, and the potential to color tears and stain contact lenses.

Despite these potential side effects, sulfasalazine is considered safe to use during pregnancy and breastfeeding, making it a viable option for women who require treatment for inflammatory arthritis or bowel disease.

To undergo a urea breath test, one must not have taken antibiotics within the last four weeks and must not have taken any antisecretory drugs, such as PPI, within the last two weeks.

Tests for Helicobacter pylori

There are several tests available to diagnose Helicobacter pylori infection. One of the most common tests is the urea breath test, where patients consume a drink containing carbon isotope 13 enriched urea. The urea is broken down by H. pylori urease, and after 30 minutes, the patient exhales into a glass tube. Mass spectrometry analysis calculates the amount of 13C CO2, which determines the presence of H. pylori. However, this test should not be performed within four weeks of treatment with an antibacterial or within two weeks of an antisecretory drug.

Another test is the rapid urease test, also known as the CLO test. This test involves mixing a biopsy sample with urea and pH indicator, and a color change indicates H. pylori urease activity. Serum antibody tests remain positive even after eradication, and the sensitivity and specificity are 85% and 80%, respectively. Culture of gastric biopsy provides information on antibiotic sensitivity, with a sensitivity of 70% and specificity of 100%. Gastric biopsy with histological evaluation alone has a sensitivity and specificity of 95-99%. Lastly, the stool antigen test has a sensitivity of 90% and specificity of 95%.

Serum levels of B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) can be measured to assess the likelihood of heart failure in patients. NT-proBNP is the inactive prohormone of BNP and is released from the left ventricle in response to ventricular strain. It acts to increase renal excretion of water and sodium, and relax vascular smooth muscle causing vasodilation.

BNP measurements are recommended for patients with suspected heart failure who have not had a previous myocardial infarction. Elevated BNP levels (>400) indicate a poor prognosis and require an urgent referral for echocardiography and specialist assessment. However, normal BNP levels do not confirm the absence of heart failure, as levels may be elevated due to other conditions such as left ventricular hypertrophy, pulmonary hypertension, or renal impairment.

NICE guidelines suggest that BNP measurements are not necessary for patients with suspected heart failure who have had a previous myocardial infarction, as urgent referral and assessment are required regardless of BNP levels. BNP levels may also be affected by medications such as ACE inhibitors and beta-blockers, as well as obesity.

Overall, BNP measurements can be a useful tool in assessing the likelihood of heart failure, but should be interpreted in conjunction with other clinical findings and patient history.

B-type natriuretic peptide (BNP) is a hormone that is primarily produced by the left ventricular myocardium in response to strain. Although heart failure is the most common cause of elevated BNP levels, any condition that causes left ventricular dysfunction, such as myocardial ischemia or valvular disease, may also raise levels. In patients with chronic kidney disease, reduced excretion may also lead to elevated BNP levels. Conversely, treatment with ACE inhibitors, angiotensin-2 receptor blockers, and diuretics can lower BNP levels.

BNP has several effects, including vasodilation, diuresis, natriuresis, and suppression of both sympathetic tone and the renin-angiotensin-aldosterone system. Clinically, BNP is useful in diagnosing patients with acute dyspnea. A low concentration of BNP (<100 pg/mL) makes a diagnosis of heart failure unlikely, but elevated levels should prompt further investigation to confirm the diagnosis. Currently, NICE recommends BNP as a helpful test to rule out a diagnosis of heart failure. In patients with chronic heart failure, initial evidence suggests that BNP is an extremely useful marker of prognosis and can guide treatment. However, BNP is not currently recommended for population screening for cardiac dysfunction.

Understanding Serology Tests for Mycoplasma Pneumonia Infection

Serology tests are used to detect antibodies in the blood that indicate the presence of an infection. In the case of Mycoplasma pneumonia, a positive result suggests an infection, but a second test is needed several weeks later to confirm this with a falling titre. The result is expressed as a dilution, with a larger denominator indicating a stronger antibody reaction. It’s important to note that antibody levels can remain raised for some time after the acute infection, which may explain the raised result for influenza A. Repeat serology is necessary to detect changing levels.

To support the diagnosis of Mycoplasma pneumonia, serology tests that demonstrate a 4-fold or greater increase or decrease in paired sera titres or a single titre greater than or equal to 1:32 are used. These tests include complement fixation, enzyme-linked immunoassay, and indirect hemagglutination. However, a sputum Gram stain is usually not helpful because M pneumonia lacks a cell wall and cannot be stained. Additionally, the bacteria is difficult to culture, requiring special culture media and up to 21 days to grow.

In summary, serology tests are an important tool for detecting Mycoplasma pneumonia infection, but a second test and careful interpretation of results are necessary for accurate diagnosis.

Inhaled Corticosteroids vs Oral Corticosteroids

Inhaled corticosteroids are a preferred treatment option for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) due to their fewer systemic effects. Unlike oral corticosteroids, inhaled corticosteroids do not cause ulceration and glucose intolerance. However, they may cause local adverse effects such as dysphonia, which is a hoarse or raspy voice. It is important to weigh the benefits and risks of each type of corticosteroid and work with a healthcare provider to determine the best treatment plan for individual needs.

There are various factors that can contribute to the development of oral ulcers. These include smoking, deficiencies in iron, folic acid, or vitamin B12, and local trauma to the oral mucosa. Additionally, anxiety and exposure to certain foods such as chocolate, coffee, peanuts, and gluten products may also play a role. However, hormonal factors are not typically associated with the development of oral ulcers.

Aphthous mouth ulcers are painful sores that are circular or oval in shape and are found only in the mouth. They are not associated with any systemic disease and often occur repeatedly, usually starting in childhood. These ulcers can be caused by damage to the mouth, such as biting the cheek or brushing too hard, or may be due to a genetic predisposition. Other factors that can trigger these ulcers include stress, certain foods, stopping smoking, and hormonal changes related to the menstrual cycle.

Aphthous ulcers are characterized by their round or oval shape, a clearly defined margin, a yellowish-grey slough on the floor, and a red periphery. They usually appear on non-keratinized mucosal surfaces, such as the inside of the lips, cheeks, floor of the mouth, or undersurface of the tongue. In most cases, investigations are not necessary, but they may be considered if an underlying systemic disease is suspected.

Treatment for aphthous ulcers involves avoiding any factors that may trigger them and providing symptomatic relief for pain, discomfort, and swelling. This may include using a low potency topical corticosteroid, an antimicrobial mouthwash, or a topical analgesic. Most ulcers will heal within two weeks without leaving any scars. However, if a mouth ulcer persists for more than three weeks, it is important to seek urgent referral to a specialist.

Eye Infections and Obstructions: Understanding the Differences

Dacryocystitis is an inflammation of the nasolacrimal sac caused by an infection resulting from an obstruction in the nasolacrimal duct. This obstruction leads to the stagnation of tears and can cause systemic illness in infants. If left untreated, the infection can spread and cause orbital cellulitis.

A chalazion, also known as a meibomian cyst, occurs when the small oil glands around the eyelashes become blocked due to inflammation. This blockage leads to the formation of a small, tender swelling within the eyelid. Chalazions can occur on either the inferior or superior eyelids.

An external hordeolum, commonly known as a stye, is a localized infection or inflammation of the eyelash follicle. This type of infection is usually caused by a staphylococcal infection.

While nasolacrimal duct obstruction can contribute to the development of dacryocystitis in infants, it should not cause inflammation and illness on its own. It is important to note that congenital nasolacrimal duct obstruction is common in infants and typically resolves within 12 months.

Ophthalmia neonatorum caused by Neisseria gonorrhoeae typically occurs within the first five days of birth and is characterized by bilateral purulent discharge. When caused by chlamydial infection, the conjunctivitis may occur after three days but can arise as late as two weeks after birth.

Emergency contraception is necessary if unprotected sex occurred within 48 hours of restarting the POP after a missed pill. In this case, the patient missed her second pill by over 12 hours and is within the 48-hour window. A pregnancy test cannot provide reassurance the day after intercourse. It is important to take additional precautions and resume taking the medication at the normal time after a missed pill for 48 hours. If the missed pill is forgotten for 24 hours, taking two pills at once may be necessary, but it is not applicable in this scenario as the missed pill has already been taken.

The progestogen only pill (POP) has simpler rules for missed pills compared to the combined oral contraceptive pill. It is important to not confuse the two. For traditional POPs such as Micronor, Noriday, Norgeston, and Femulen, as well as Cerazette (desogestrel), if a pill is less than 3 hours late, no action is required and pill taking can continue as normal. However, if a pill is more than 3 hours late (i.e. more than 27 hours since the last pill was taken), action is needed. If a pill is less than 12 hours late, no action is required. But if a pill is more than 12 hours late (i.e. more than 36 hours since the last pill was taken), action is needed.

If action is needed, the missed pill should be taken as soon as possible. If more than one pill has been missed, only one pill should be taken. The next pill should be taken at the usual time, which may mean taking two pills in one day. Pill taking should continue with the rest of the pack. Extra precautions, such as using condoms, should be taken until pill taking has been re-established for 48 hours.

While the use of combined oral contraceptive pills (COCP) may be restricted for obese patients, all other contraceptive options are considered safe with a UK Medical Eligibility Criteria (UKMEC) rating of 1. It has been established that Depo-Provera may lead to weight gain, but there is no indication that the dosage of progestogen-only pills or other forms of contraception needs to be altered for obese patients.

Contraception for Obese Patients

Obesity can increase the risk of venous thromboembolism in women who take the combined oral contraceptive pill (COCP). Therefore, it is recommended that patients with a BMI of 30-34 kg/m² should use the COCP with caution (UKMEC 2), while those with a BMI of 35 kg/m² or higher should avoid it altogether (UKMEC 3). Additionally, the combined contraceptive transdermal patch may be less effective in patients who weigh over 90kg.

It is important to note that all other methods of contraception have a UKMEC of 1, meaning they are considered safe for use in obese patients. However, patients who have undergone gastric sleeve/bypass/duodenal switch surgeries cannot use oral contraception, including emergency contraception, due to its lack of efficacy.

In summary, obese patients should be cautious when using the COCP and consider alternative methods of contraception. It is important to discuss contraceptive options with a healthcare provider to determine the best course of action based on individual needs and medical history.

Due to the significantly elevated blood pressure of this relatively young patient, despite being on four antihypertensive medications, it is necessary to consider the possibility of a secondary cause. Therefore, referral to secondary care is recommended for further investigation. As per NICE guidelines, if the blood pressure remains uncontrolled even after using the optimal or maximum tolerated doses of four medications, it is advisable to seek expert advice if it has not already been obtained.

Hypertension, or high blood pressure, is a common condition that can lead to serious health problems if left untreated. The National Institute for Health and Care Excellence (NICE) has published updated guidelines for the management of hypertension in 2019. Some of the key changes include lowering the threshold for treating stage 1 hypertension in patients under 80 years old, allowing the use of angiotensin receptor blockers instead of ACE inhibitors, and recommending the use of calcium channel blockers or thiazide-like diuretics in addition to ACE inhibitors or angiotensin receptor blockers.

Lifestyle changes are also important in managing hypertension. Patients should aim for a low salt diet, reduce caffeine intake, stop smoking, drink less alcohol, eat a balanced diet rich in fruits and vegetables, exercise more, and lose weight.

Treatment for hypertension depends on the patient’s blood pressure classification. For stage 1 hypertension with ABPM/HBPM readings of 135/85 mmHg or higher, treatment is recommended for patients under 80 years old with target organ damage, established cardiovascular disease, renal disease, diabetes, or a 10-year cardiovascular risk equivalent to 10% or greater. For stage 2 hypertension with ABPM/HBPM readings of 150/95 mmHg or higher, drug treatment is recommended regardless of age.

The first-line treatment for patients under 55 years old or with a background of type 2 diabetes mellitus is an ACE inhibitor or angiotensin receptor blocker. Calcium channel blockers are recommended for patients over 55 years old or of black African or African-Caribbean origin. If a patient is already taking an ACE inhibitor or angiotensin receptor blocker, a calcium channel blocker or thiazide-like diuretic can be added.

If blood pressure remains uncontrolled with the optimal or maximum tolerated doses of four drugs, NICE recommends seeking expert advice or adding a fourth drug. Blood pressure targets vary depending on age, with a target of 140/90 mmHg for patients under 80 years old and 150/90 mmHg for patients over 80 years old. Direct renin inhibitors, such as Aliskiren, may be used in patients who are intolerant of other antihypertensive drugs, but their role is currently limited.

Hypertension can be a possible side effect of taking leflunomide.

Leflunomide: A DMARD for Rheumatoid Arthritis

Leflunomide is a type of disease modifying anti-rheumatic drug (DMARD) that is commonly used to manage rheumatoid arthritis. It is important to note that this medication has a very long half-life, which means that its teratogenic potential should be taken into consideration. As such, it is contraindicated in pregnant women, and effective contraception is essential during treatment and for at least two years after treatment in women, and at least three months after treatment in men. Caution should also be exercised in patients with pre-existing lung and liver disease.

Like any medication, leflunomide can cause adverse effects. Some of the most common side effects include gastrointestinal issues such as diarrhea, hypertension, weight loss or anorexia, peripheral neuropathy, myelosuppression, and pneumonitis. To monitor for any potential complications, patients taking leflunomide should have their full blood count (FBC), liver function tests (LFT), and blood pressure checked regularly.

If a patient needs to stop taking leflunomide, it is important to note that the medication has a very long wash-out period of up to a year. To help speed up the process, co-administration of cholestyramine may be necessary. Overall, leflunomide can be an effective treatment option for rheumatoid arthritis, but it is important to carefully consider its potential risks and benefits before starting treatment.

Treatment Options for Osteoporosis: A Comparison

Osteoporosis is a common condition that affects bone density and increases the risk of fractures. There are several treatment options available, each with its own advantages and disadvantages. In this article, we will compare the most commonly used treatments for osteoporosis.

Denosumab is a RANK-ligand inhibitor that reduces osteoclast activity and pre-osteoclast to osteoclast maturation, leading to downregulation of bone resorption. It is administered once every six months via subcutaneous injection, making it a convenient option for patients who struggle with compliance. Denosumab is particularly suitable for patients who have not tolerated bisphosphonates and have a low BMI.

Calcitonin is available as an intravenous preparation for the treatment of acute hypercalcaemia. However, oral calcitonin is not used as chronic therapy due to the risk of osteosarcoma.

Raloxifene is a selective oestrogen receptor modulator that is less effective than bisphosphonates as a treatment for osteoporosis. However, it does reduce the risk of breast cancer in women who take it.

Strontium ranelate is reserved as a treatment for osteoporosis for patients who are unable to tolerate other therapies. However, it may be associated with an increased risk of ischaemic cardiovascular events.

Teriparatide is a synthetic parathyroid hormone analogue given once a day as a subcutaneous injection for osteoporosis. However, it may not be a preferred option for a 75-year-old woman.

In conclusion, the choice of treatment for osteoporosis depends on several factors, including the patient’s age, medical history, and tolerance to different therapies. Denosumab is a convenient option for patients who struggle with compliance, while raloxifene may be suitable for women who want to reduce their risk of breast cancer. However, it is important to discuss the risks and benefits of each treatment option with a healthcare professional before making a decision.

Hyponatraemia is a known side effect of SSRIs, with sertraline being the specific medication associated with this condition. Other drugs that can cause low sodium levels include chlorpropramide, carbamazepine, tricyclic antidepressants, lithium, MDMA/ecstasy, tramadol, haloperidol, vincristine, desmopressin, and fluphenazine.

Side-Effects of SSRIs

SSRIs, or selective serotonin reuptake inhibitors, are commonly prescribed antidepressants. However, they can cause adverse effects, with gastrointestinal symptoms being the most common. Patients taking SSRIs are also at an increased risk of gastrointestinal bleeding, especially if they are also taking NSAIDs. To prevent this, a proton pump inhibitor should be prescribed. Hyponatraemia is another potential side-effect, and patients should be vigilant for increased anxiety and agitation after starting a SSRI. Fluoxetine and paroxetine have a higher propensity for drug interactions.

Citalopram, a type of SSRI, has been associated with dose-dependent QT interval prolongation. The Medicines and Healthcare products Regulatory Agency (MHRA) has advised that citalopram and escitalopram should not be used in patients with congenital long QT syndrome, known pre-existing QT interval prolongation, or in combination with other medicines that prolong the QT interval. The maximum daily dose for citalopram is now 40 mg for adults, 20 mg for patients older than 65 years, and 20 mg for those with hepatic impairment.

SSRIs can also interact with other medications, such as NSAIDs, warfarin/heparin, aspirin, and triptans. NICE guidelines recommend avoiding SSRIs and considering mirtazapine for patients taking warfarin/heparin. Triptans should be avoided with SSRIs.

When starting antidepressant therapy, patients should be reviewed by a doctor after 2 weeks. For patients under the age of 30 years or at increased risk of suicide, they should be reviewed after 1 week. If a patient responds well to antidepressant therapy, they should continue treatment for at least 6 months after remission to reduce the risk of relapse.

When stopping a SSRI, the dose should be gradually reduced over a 4 week period, except for fluoxetine. Paroxetine has a higher incidence of discontinuation symptoms, which can include mood changes, restlessness, difficulty sleeping, unsteadiness, sweating, gastrointestinal symptoms, and paraesthesia.

When it comes to children with fevers, healthcare professionals consider appearing unwell to be a red flag. Additionally, not responding appropriately to social cues is an amber flag, as is poor feeding. In children over 12 months old, a respiratory rate exceeding 40 breaths per minute is an amber flag, while a rate over 60 is a red flag. Finally, a heart rate over 150 beats per minute is an amber flag for children between 12 and 24 months old.

The NICE Feverish illness in children guidelines were introduced in 2007 and updated in 2013 to provide a ‘traffic light’ system for assessing the risk of febrile illness in children under 5 years old. The guidelines recommend recording the child’s temperature, heart rate, respiratory rate, and capillary refill time, as well as looking for signs of dehydration. Measuring temperature should be done with an electronic thermometer in the axilla for children under 4 weeks or with an electronic/chemical dot thermometer in the axilla or an infra-red tympanic thermometer. The risk stratification table categorizes children as green (low risk), amber (intermediate risk), or red (high risk) based on their symptoms. Management recommendations vary depending on the risk level, with green children managed at home, amber children provided with a safety net or referred to a specialist, and red children urgently referred to a specialist. The guidelines also advise against prescribing oral antibiotics without an apparent source of fever and note that a chest x-ray is not necessary if a child with suspected pneumonia is not being referred to the hospital.

Understanding Nephrotic and Nephritic Syndrome: Symptoms and Causes

Nephrotic syndrome is characterized by proteinuria, hypoalbuminaemia, oedema, and hyperlipidaemia, while nephritic syndrome is defined by acute kidney injury, hypertension, oliguria, and urinary sediment. Both syndromes can be caused by various renal diseases and are a constellation of several symptoms.

In nephritic syndrome, increased cellularity within the glomeruli and a leucocytic infiltrate cause an inflammatory reaction that injures capillary walls, leading to red cells in urine and decreased glomerular filtration rate. Hypertension is likely due to fluid retention and increased renin release. Examples of conditions causing nephritic syndrome include diffuse proliferative glomerulonephritis, IgA nephropathy, and lupus nephritis.

Acute nephritic syndrome is the most serious and requires immediate referral to secondary care, while patients with nephrotic syndrome will also be referred but usually do not require acute admission.

Importance of Immediate Actions for Suspected TIA Patients

When a patient presents with symptoms of a suspected transient ischaemic attack (TIA), immediate actions are crucial to reduce the risk of stroke. The National Institute for Health and Care Excellence (NICE) guidelines recommend administering aspirin 300 mg immediately, even in cases of unconfirmed TIA. Referral for specialist assessment should also be made immediately, with the patient seen within 24 hours. The ABCD2 score is no longer recommended for risk stratification, as all suspected cases of TIA should be regarded as potentially high risk of stroke. While antihypertensives may be necessary, initiating aspirin is a higher priority. Additionally, patients should be advised not to drive for at least one month after a TIA. Taking these immediate actions can greatly improve outcomes for patients with suspected TIA.

Psoriasis is an extraintestinal manifestation that is not associated with the activity of the disease.

Crohn’s disease is a type of inflammatory bowel disease that can affect any part of the digestive tract. The National Institute for Health and Care Excellence (NICE) has published guidelines for managing this condition. Patients are advised to quit smoking, as it can worsen Crohn’s disease. While some studies suggest that NSAIDs and the combined oral contraceptive pill may increase the risk of relapse, the evidence is not conclusive.

To induce remission, glucocorticoids are typically used, but budesonide may be an alternative for some patients. Enteral feeding with an elemental diet may also be used, especially in young children or when there are concerns about steroid side effects. Second-line options include 5-ASA drugs, such as mesalazine, and add-on medications like azathioprine or mercaptopurine. Infliximab is useful for refractory disease and fistulating Crohn’s, and metronidazole is often used for isolated peri-anal disease.

Maintaining remission involves stopping smoking and using azathioprine or mercaptopurine as first-line options. Methotrexate is a second-line option. Surgery is eventually required for around 80% of patients with Crohn’s disease, depending on the location and severity of the disease. Complications of Crohn’s disease include small bowel cancer, colorectal cancer, and osteoporosis. Before offering azathioprine or mercaptopurine, it is important to assess thiopurine methyltransferase (TPMT) activity.